Troponin I and Creatine Kinase MB do not provide comparable information after PCI

Carl Gunnar Gustavsson1, Margareta Nilson

  • 1Department of Cardiology, University Hospital MAS, Malmoe, Sweden. CG@Gustavsson.se

Insights

Cardiac troponin I (cTnI) and creatine kinase-MB (CK-MB) levels were compared after PCI. Results show cTnI identifies significantly more procedure-related infarctions than CK-MB.

Area of Science:

  • Cardiology
  • Biomarker analysis
  • Myocardial infarction detection

Background:

  • Percutaneous coronary intervention (PCI) can lead to myocardial injury.
  • Accurate detection of procedure-related myocardial infarction is crucial.
  • Cardiac troponin I (cTnI) and creatine kinase-MB (CK-MB) are commonly used biomarkers.

Purpose of the Study:

  • To compare the diagnostic performance of cTnI and CK-MB in detecting myocardial infarction after PCI.
  • To evaluate biomarker elevation relative to the 99th percentile upper reference limit (URL).

Main Methods:

  • Compared cTnI and CK-MB levels in 489 patients post-PCI with normal baseline levels.
  • Stratified biomarker levels as multiples of the 99% URL.
  • Defined procedure-related infarctions as levels > 3x 99% URL.

Main Results:

  • cTnI elevation (> 3x 99% URL) occurred in 60% of patients, while CK-MB elevation occurred in 12%.
  • cTnI was elevated (> 10x 99% URL) in all CK-MB infarction cases.
  • CK-MB often remained normal despite elevated cTnI, indicating limited overlap.

Conclusions:

  • The infarction rate after PCI is over five-fold higher when assessed by cTnI compared to CK-MB.
  • cTnI demonstrates superior sensitivity for detecting procedure-related myocardial injury post-PCI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...